tirzepatide cardiovascular risk compared with semaglutide and 10-year disease reduction in obesity: post-hoc analysis of the SURMOUNT-5 trial Mounjaro, Zepbound Lowers Risk of

That said, a major barrier to achieving widespread adoption lies in affordability according to our survey, 45% of current patients cite cost as one of the primary reasons for discontinuing their medication

This dual therapy is one of the most effective tools we offer to reset your biology and help you feel in control of your health again

Most frequently these causes are B12 or folate deficiency, myelodysplasia, or liver disease

Sustainable Results: Our focus is not just on helping you lose weight but also on giving you the knowledge and tools to maintain a healthy lifestyle for the long term

Semaglutide data vary by cohort and method, but several analyses report substantial lean mass reductions during weight loss phases

Some women may notice improvements in symptoms within weeks, while others may require longer treatment periods